860 filings
Page 27 of 43
D
xpr83jnc03
16 Nov 17
$15M in equity / options / securities to be acquired, sold $1.2M, 20 investors
12:00am
8-K
8e46wz4e3vth
8 Nov 17
Entry into a Material Definitive Agreement
12:00am
8-K
9ov8k208383znio76
2 Nov 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
edg4pupi2y8i
13 Oct 17
Cytodyn Provides Update on Pro 140 Combination Therapy Pivotal Trial In Hiv Patients Following Constructive Meeting with Fda
12:00am
8-K
lz8vxes1sn5
11 Oct 17
Entry into a Material Definitive Agreement
12:00am
424B5
rxpys39c
11 Oct 17
Prospectus supplement for primary offering
12:00am
8-K
470k3
5 Oct 17
CytoDyn Receives Orphan Drug Designation for PRO 140
12:00am
424B5
gsijb6q58 0wafu
8 Sep 17
Prospectus supplement for primary offering
12:00am
8-K
9dlx igdn
8 Sep 17
Entry into a Material Definitive Agreement
12:00am
8-K
t02tz3skwkyao nz19u9
6 Sep 17
CytoDyn Provides Further Update on PRO 140 Pivotal Combination
12:00am
8-K
aranw0xy5osrj53i auk
25 Aug 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
ia0xum 0kpldjtby4zze
21 Aug 17
CytoDyn Provides Update on PRO 140 Pivotal Combination Therapy Trial in Patients with HIV
12:00am
8-K
hk5kp
9 Aug 17
Cytodyn Provides Update on Enrollment
12:00am
8-K
dew561kidxzoc67 ij8
31 Jul 17
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
12:00am